Evidence map›Paper›PMID 30943906›Full record

ArticleBMC infectious diseases2019

Lactococcus garvieae, an unusual pathogen in infective endocarditis: case report and review of the literature.

Alexandre Malek, Alejandro De la Hoz, Sara Isabel Gomez-Villegas, Cima Nowbakht, Cesar A Arias

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Infective endocarditis due toJournal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Genomic investigation ofMicrobiology spectrum · 2024
    Article
  11. Redefining piscine lactococcosis.Applied and environmental microbiology · 2024
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Evidence of pediatric sepsis caused by a drug resistantEmerging microbes & infections · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Alexandre MalekDepartment of Internal Medicine, Division of Infectious Diseases, UTHealth - McGovern Medical School, Houston, TX, USA.
Alejandro De la HozGrupo de Investigación en Enfermedades Infecciosas, Hospital Universitario San Ignacio, Pontificia Universidad Javeriana, Bogotá, Colombia.
Sara Isabel Gomez-VillegasUniversidad de Antioquia, School of Medicine, Medellin, Colombia.
Cima NowbakhtDepartment of Internal Medicine, Division of Infectious Diseases, UTHealth - McGovern Medical School, Houston, TX, USA.
Cesar A AriasDepartment of Internal Medicine, Division of Infectious Diseases, UTHealth - McGovern Medical School, Houston, TX, USA. cesar.arias@uth.tmc.edu.
The University of Texas Health Science Center at Houston · USPontificia Universidad Javeriana · COUniversidad de Antioquia · CO

Funding

National Institute of Allergy and Infectious Diseases K24-AI114818
6 · The paper itself

Abstract

backgroundLactococcus garvieae is an unusual cause of infective endocarditis (IE). No current diagnostic and therapeutic guidelines are available to treat IE caused by these organisms. Based on a case report, we provide a review of the literature of IE caused by L. garvieae and highlight diagnostic and treatment challenges of these infections and implications for management. CASE PRESENTATION: A 50-year-old Asian male with mitral prosthetic valve presented to the hospital with intracranial haemorrhage, which was successfully treated. Three weeks later, he complained of generalized malaise. Further work up revealed blood cultures positive for Gram-positive cocci identified as L. garvieae by MALDI-TOF. An echocardiogram confirmed the diagnosis of IE. Susceptibility testing showed resistance only to clindamycin. Vancomycin plus gentamicin were started as empirical therapy and, subsequently, the combination of ceftriaxone plus gentamicin was used after susceptibility studies were available. After two weeks of combination therapy, ceftriaxone was continued as monotherapy for six additional weeks with good outcome.

conclusionsTwenty-five cases of IE by Lactococcus garvieae have been reported in the literature. Compared to other Gram-positive cocci, L. garvieae affects more frequently patients with prosthetic valves. IE presents in a subacute manner and the case fatality rate can be as high as 16%, comparable to that of streptococcal IE (15.7%). Reliable methods for identification of L. garvieae include MALDI-TOF, 16S RNA PCR, API 32 strep kit and BD Automated Phoenix System. Recommended antimicrobials for L. garvieae IE are ampicillin, amoxicillin, ceftriaxone or vancomycin in monotherapy or in combination with gentamicin.

Indexed as

Anti-Bacterial AgentsCeftriaxoneDrug Therapy, CombinationEchocardiographyEndocarditis, BacterialGentamicinsGram-Positive Bacterial InfectionsHeart Valve ProsthesisHumansLactococcusMaleMicrobial Sensitivity TestsMiddle AgedSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationVancomycinAnti-Bacterial AgentsCeftriaxoneGentamicinsVancomycinCase reportDiagnosisGram positive cocciInfective endocarditisLactococcusRisk factorsTreatment

Identifiers

PMID30943906
PMCPMC6446321
OpenAlexW2928440760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.